Viewing Study NCT01031303

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-01-09 @ 1:18 AM
Study NCT ID: NCT01031303
Status: COMPLETED
Last Update Posted: 2011-10-05
First Post: 2009-12-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age
Sponsor: Sanofi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diphtheria View
None Tetanus View
None Pertussis View
None Poliomyelitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diphtheria View
None Tetanus View
None Pertussis View
None Poliomyelitis View
None PENTAXIM™ View
None TETRAXIM™ View